original ) (raw )Invasive aspergillosis in patients with hematologic malignancies: incidence and description of 127 cases enrolled in a single institution prospective survey from 2004 to 2009
M. Sobh
Haematologica, 2011
View PDFchevron_right
International Multicenter Experience in the Treatment of Invasive Aspergillosis in Immunocompromised Cancer Patients
Marjorie Batista
Mediterranean Journal of Hematology and Infectious Diseases
View PDFchevron_right
The diagnosis and treatment of invasive aspergillosis in Dutch haematology units facing a rapidly increasing prevalence of azole-resistance. A nationwide survey and rationale for the DB-MSG 002 study protocol
Lambert Span
Mycoses
View PDFchevron_right
Invasive aspergillosis in haematological malignancies: Clinical findings and management for intensive chemotherapy completion
Anna Nosari , Enrica Morra
American Journal of Hematology, 2001
View PDFchevron_right
Infections Due to Aspergillus terreus: A Multicenter Retrospective Analysis of 83 Cases
Irja Lutsar
Clinical Infectious Diseases, 2004
View PDFchevron_right
Invasive aspergillosis in patients with hematological malignancies in the Czech and Slovak republics: Fungal InfectioN Database (FIND) analysis, 2005–2009
Lubos Drgona , Elena Tothova
International Journal of Infectious Diseases, 2013
View PDFchevron_right
Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study
Gottfried Dölken
International Journal of Antimicrobial Agents, 2017
View PDFchevron_right
Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry
Nkechi Azie , Elias Anaissie
Journal of Infection, 2012
View PDFchevron_right
Invasive Aspergillosis: New Insights into Disease, Diagnostic and Treatment
Current Pharmaceutical Design
Bentham Science Publishers
View PDFchevron_right
Azole-resistant invasive aspergillosis in a patient with acute myeloid leukaemia in Germany
T. Halbsguth , Axel Hamprecht , N. Kutsch
Euro surveillance : bulletin Européen sur les maladies transmissibles = European communicable disease bulletin, 2012
View PDFchevron_right
Comparative analysis of prognostic indicators of aspergillosis in haematological malignancies and HIV infection
Giuseppe Leone
Journal of Infection, 1997
View PDFchevron_right
Clinical significance of Aspergillus fungaemia in patients with haematological malignancies and invasive aspergillosis
Marcio Nucci
British Journal of Haematology, 2001
View PDFchevron_right
Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience
Andreas Petzer
British Journal of Haematology, 2005
View PDFchevron_right
Molecular Detection of Invasive Aspergillosis in Hematologic Malignancies
Abdolvahab Alborzi
Infection, 2008
View PDFchevron_right
Invasive aspergillosis in patients with acute leukemia: update on morbidity and mortality—SEIFEM-C Report
Anna Candoni
2007
View PDFchevron_right
A Prospective Multicenter Cohort Surveillance Study of Invasive Aspergillosis in Patients with Hematologic Malignancies in Greece: Impact of the Revised EORTC/MSGERC 2020 Criteria
Helen Sambatakou
Journal of Fungi
View PDFchevron_right
The epidemiology and prevention of invasive aspergillosis
Rana Hajjeh , Brent Lasker
Journal of Hospital Infection, 1998
View PDFchevron_right
Application of the 2008 Definitions for Invasive Fungal Diseases to the Trial Comparing Voriconazole Versus Amphotericin B for Therapy of Invasive Aspergillosis: A Collaborative Study of the Mycoses Study Group (MSG 05) and the European Organization for Research and Treatment of Cancer Infectious...
Monica Slavin
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014
View PDFchevron_right
Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study)
Pascale salameh
Journal of Antimicrobial Chemotherapy, 2010
View PDFchevron_right
The Changing Epidemiology of Invasive Aspergillosis in the Non-Traditional Host: Risk Factors and Outcomes
Ameet Hingwe
Pulmonary and critical care medicine, 2016
View PDFchevron_right
Treatment of Invasive Aspergillosis with Posaconazole in Patients Who Are Refractory to or Intolerant of Conventional Therapy: An Externally Controlled Trial
Thomas Walsh
Clinical Infectious Diseases, 2007
View PDFchevron_right
Clinical applicability of the new EORTC/MSG classification for invasive pulmonary aspergillosis in patients with hematological malignancies and autopsy-confirmed invasive aspergillosis
lourdes vazquez
Annals of Hematology, 2003
View PDFchevron_right
Diagnosis and management of invasive aspergillosis in adult neutropenic haemato-oncology patients
Muhammed Ceesay
2014
View PDFchevron_right
The prevention of invasive aspergillosis-a realistic goal?
Roderick Hay
Journal of Antimicrobial Chemotherapy, 1993
View PDFchevron_right
Executive summary of clinical practice guideline for the management of invasive diseases caused by Aspergillus: 2018 Update by the GEMICOMED-SEIMC/REIPI
Isabel Ruiz-camps
Enfermedades Infecciosas Y Microbiologia Clinica, 2019
View PDFchevron_right
Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study
Anna Candoni
Haematologica, 2010
View PDFchevron_right
Advances in the serological diagnosis of invasive Aspergillus infections in patients with haematological disorders
Katrien Lagrou
Mycoses, 2007
View PDFchevron_right